Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BenevolentAI SA

BAI
Current price
0.77 EUR -0.01 EUR (-1.28%)
Last closed 0.78 EUR
ISIN LU2355630455
Sector Healthcare
Industry Biotechnology
Exchange Euronext Amsterdam
Capitalization 100 252 725 EUR
Yield for 12 month +2.67 %
1Y
3Y
5Y
10Y
15Y
BAI
21.11.2021 - 28.11.2021

BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company's development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, an oral brain penetrant CHK1 inhibitor under preclinical study for the treatment of Glioblastoma Multiforme; BEN-34712, a preclinical candidate for the potential treatment of ALS; and various candidates for the treatment of fibrosis and Parkinson's disease. It has collaboration agreements with AstraZeneca and Merck to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom. Address: 4-8 Maple Street, London, United Kingdom, W1T 5HD

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.83 EUR

P/E ratio

Dividend Yield

Current Year

+8 745 357 EUR

Last Year

+12 597 322 EUR

Current Quarter

Last Quarter

Current Year

+8 745 357 EUR

Last Year

+12 597 322 EUR

Current Quarter

Last Quarter

Key Figures BAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -62 420 689 EUR
Operating Margin TTM -1111.19 %
PE Ratio
Return On Assets TTM -32.76 %
PEG Ratio
Return On Equity TTM -53.04 %
Wall Street Target Price 0.83 EUR
Revenue TTM 4 841 758 EUR
Book Value 0.57 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -46.5 %
Dividend Yield
Gross Profit TTM 10 503 075 EUR
Earnings per share -0.64 EUR
Diluted Eps TTM -0.64 EUR
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BAI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 6.5775
Price Sales TTM 20.7059
Enterprise Value EBITDA -0.6491
Price Book MRQ 0.8481

Financials BAI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BAI

For 52 weeks

0.46 EUR 1.66 EUR
50 Day MA 0.75 EUR
Shares Short Prior Month
200 Day MA 0.67 EUR
Short Ratio
Shares Short
Short Percent